Form 4 for RMD ResMed|
Accepted 2025-05-27 00:00:00 ET · period of report 2025-05-22 · accession 0001127602-25-015607 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-27 | 2025-05-22 | RMD | Sandercock Brett | CFO | S - Sale | $244.59 | -3,644 | 86.3K | -4% | -$891.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-05-22 | S | D | 3,644 | $244.59 | 86,283 | D | — | — | (F2) Includes 62.6994 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan. |